What is Competitive Landscape of FIGS Company?

How is FIGS reshaping healthcare apparel markets?

FIGS pivoted in early 2025 toward institutional B2B through its TEAMS platform, shifting from DTC to large healthcare contracts. Founded in 2013, it transformed scrubs into a premium lifestyle category and reported revenues near $600,000,000 by FY2025.

FIGS faces competition from legacy uniform suppliers, fast-fashion entrants, and premium niche brands while leveraging brand loyalty, direct channels, and product diversification including footwear and outer-scrubs. See FIGS Porter's Five Forces Analysis for structured insights.

FIGS designs premium healthcare apparel focused on comfort, performance and style, selling primarily D2C with growing institutional TEAMS contracts; the value proposition centers on high-margin, tech-infused fabrics and strong brand loyalty among clinical professionals.

Market Share and Category Standing

As of late 2025 FIGS holds an estimated 15 percent of the branded medical scrub market in the United States, leading the premium segment and the direct-to-consumer channel.

Financial Profile

Gross margins remain strong at roughly 67–69 percent, supported by a zero-debt balance sheet and robust operating cash flow reported through FY2025.

Customer Base and Retention

FIGS serves over 2.6 million active professional users with an approximate repeat purchase rate of 70 percent, indicating strong customer lifetime value in the scrubs industry landscape.

Geographic Reach

Operations extend to more than 15 international markets, with international revenue contributing nearly 12 percent of total revenue growth as of 2025.

FIGS has evolved from an individual clinician-focused brand to a hybrid model emphasizing institutional sales via its TEAMS platform, increasing penetration into hospital and clinic procurement while retaining D2C strength.

Competitive Advantages and Pressures

FIGS leads the D2C premium medical apparel market but faces mid-tier competition and margin/volume trade-offs as it pursues broader market share.

• Direct-to-consumer leadership with strong brand equity and community engagement
• High gross margins relative to apparel peers, boosting reinvestment capacity
• Growing institutional TEAMS contracts diversify revenue but require scale and customization
• Mid-tier price competition and private-label entrants pressure broader penetration

Investor assessments in 2025 rank FIGS as a top-tier growth stock in specialty retail, citing its cash generation and balance sheet strength; for deeper marketing and distribution context see Marketing Strategy of FIGS.

Complete FIGS Strategy Bundle

• 6 Full Frameworks, 1 Company – All Pre-Researched
• Each Framework Fully Sourced with Real Company Data
• Built for Strategy Courses, Case Studies & MBA Programs
• Adapt to Your Assignment – No Starting from Scratch
• 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's

GET FULL BUNDLE

FIGS monetizes through direct-to-consumer ecommerce, wholesale partnerships, and B2B institutional contracts, with product, accessories, and repeat-purchase subscription incentives driving revenue. In 2025 FIGS reported merchandise revenue growth driven by higher ASPs and expansion into clinical footwear and base layers.

Key revenue streams: online retail sales, corporate bulk orders, licensed collaborations, and limited wholesale distribution into healthcare retailers and specialty channels.

Legacy wholesale rivals

Careismatic Brands (Cherokee, Dickies Medical) leads on volume and retail penetration despite 2024 restructuring; competes on price and wide physical distribution.

Heritage incumbents

Barco Uniforms leverages the Grey’s Anatomy brand and long-standing retail channels to attract buyers who value tradition and in-store availability.

D2C fashion challengers

Jaanuu targets style-focused clinicians with fashion-forward designs and celebrity collaborations, directly challenging FIGS in the premium D2C segment.

Value-focused disruptors

Mandala uses transparent pricing and lower price points to capture cost-conscious professionals seeking FIGS-like aesthetics at reduced cost.

Indirect lifestyle entrants

Nike and Lululemon have entered via technical base layers and footwear for healthcare workers, leveraging expertise in performance fabrics to encroach on FIGS’ addressable market.

Consolidation and PE activity

Private equity interest in mid-sized scrub brands in 2024–2025 indicates consolidation risk; well-funded new owners can scale distribution and compress margins.

Competitive dynamics for FIGS combine brand equity and pricing pressure; market share shifts depend on channel reach, ASP management, and product innovation. See a deeper corporate growth view in Growth Strategy of FIGS.

Competitive snapshot — measurable factors

Key comparative metrics investors and strategists monitor in the medical apparel market:

• Revenue mix: D2C vs wholesale proportions and trends.
• Average selling price (ASP): premium positioning vs discount competitors.
• Retail footprint: physical store count and distribution reach for legacy players.
• PE/consolidation activity: capital inflows that can scale rivals rapidly.

From PESTLE Factors to Full Strategy Bundle

• PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
• Every Strategic Angle Covered – Nothing Left to Research
• Pre-filled with Company-Specific Research
• No Missing Sections for Your Case Study
• One Download Covers Your Entire Company Analysis

GET COMPLETE BUNDLE

FIGS patented FIONx fabric and D2C analytics drove rapid growth since launch, with the brand reaching over 1.2 million customers by 2025 and sustained gross margins above 60%. Strategic TEAMS B2B expansion and limited-edition drops created retention and recurring revenue streams, solidifying FIGS competitive edge in the medical apparel market share.

Proprietary supply-chain controls and collaborations like New Balance x FIGS reinforced product credibility and broadened category reach, increasing average order value and lowering CAC through community-driven referrals.

Proprietary Fabric Technology

FIONx integrates four-way stretch, moisture-wicking, and antimicrobial properties at the fiber level, creating a tactile and performance gap versus competitors in the scrubs industry landscape.

Supply-Chain and Quality Control

Controlled sourcing and manufacturing enforce consistent feel and durability, raising barriers for new entrants and protecting FIGS competitive advantages and disadvantages.

Brand Equity & Community

Community-centric marketing produced strong organic word-of-mouth; social channels and clinician advocacy reduce Customer Acquisition Cost and support long-term loyalty.

D2C Data Advantage

Direct customer relationships enable predictive inventory, rapid product iteration, and limited-edition strategies that drive immediate revenue spikes and higher conversion rates.

TEAMS B2B portal increases switching costs for practices and boosts recurring institutional orders, contributing to a diversified revenue mix and reinforcing FIGS business strategy versus wholesalers.

Core Competitive Strengths

FIGS competitive analysis highlights product tech, brand loyalty, D2C data, and B2B lock-in as primary differentiators against FIGS competitors in the healthcare apparel competition.

• Proprietary FIONx fabric with fiber-level treatments
• High gross margin model: > 60% reported in 2025 disclosures
• TEAMS portal creating practice-level stickiness
• Collaborations (example: New Balance partnership) expanding category authority

For historical context on the brand's origins and growth trajectory see Brief History of FIGS

FIGS Business Model + Strategy Bundle

• Ideal for Essays, Case Studies & Slides
• Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
• Company-Specific Content Already Organized
• One Bundle Replaces Days of Independent Research
• Buy the Bundle Once. Use Across All Your Assignments

GET COMPLETE ANALYSIS

FIGS occupies a leading position in the premium segment of the medical apparel market, leveraging a direct-to-consumer model, strong brand recognition, and a growing digital ecosystem; risks include raw material inflation, regulatory scrutiny over antimicrobial claims, and intensifying competition from vertically integrated incumbents and digitally native challengers. The future outlook depends on execution of international expansion, meeting sustainability targets, and scaling custom-fit innovations to defend and grow FIGS market share.

Performance-Focused Workwear

The scrubs industry landscape in 2025 shows athleticization of uniforms, with technical fabrics for temperature regulation and fluid resistance driving product differentiation and premium pricing.

Sustainability Momentum

Demand for recycled polyester and ethical manufacturing is rising; FIGS has targeted 50 percent sustainable content across its catalog by 2026 and increased recycled-material usage in 2025 collections.

Labor Market Tailwinds

Persistent global shortages of healthcare workers and burnout make premium uniforms a retention tool; hospitals subsidizing scrubs supports higher ASPs and recurring revenue opportunities.

Cost and Regulatory Pressure

Rising raw material costs and potential tightening of antimicrobial textile claims create margin and compliance risks that require R&D and supply-chain resilience.

FIGS competitive analysis must factor in market concentration: as of 2025, FIGS is one of the leading DTC premium brands with low-to-mid single-digit market share in the overall $3–4 billion US medical apparel market, while facing competition from legacy suppliers, private-label hospital contracts, and digital-first rivals focused on price or niche specialization; strategic responses include supply-chain verticalization, personalization (3D scanning, custom-fit), and expanded international logistics to capture privatizing healthcare demand.

Key Opportunities and Challenges

FIGS business strategy should prioritize margins, sustainable sourcing, and technological differentiation to maintain leadership amid evolving competition.

• Opportunity: Personalized apparel via 3D body scanning can raise ASPs and lifetime value.
• Opportunity: International expansion into emerging markets where privatization drives premium demand.
• Challenge: Antimicrobial claim regulation could force reformulation or relabeling costs.
• Challenge: Raw material inflation and freight volatility pressure gross margin; hedging and multi-sourcing required.

For investor research on FIGS competitive landscape and targeted customer insights, see Target Market of FIGS

From Five Forces to Full Company Analysis

• Includes SWOT, PESTLE, BMC, BCG and 4P's
• Pre-Researched with Company-Specific Data
• Best Value for a Complete Analysis
• Ready to Adapt for Your Case Study
• Ready for Essays and Slidesd

GET FULL BUNDLE